Biomarkers Determining Prognosis of Atrial Fibrillation Ablation
- 22 April 2019
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 26 (5) , 925-937
Abstract
Catheter ablation for rhythm control is recommended in specific patient populations with paroxysmal, persistent, or long-standing persistent atrial fibrillation. Pulmonary vein isolation is the cornerstone of the ablative therapy for atrial fibrillation. However, relapse is still common since the single procedure efficacy of atrial fibrillation ablation was estimated to be 60-80% in paroxysmal and 50-70% in persistent atrial fibrillation. It is important to identify predictors of successful atrial fibrillation patients ablation. In the present review, we will assess the role of available biomarkers to predict responders of an initial atrial fibrillation catheter ablation. Emphasis has been given on the role of myocardial injury biomarkers, natriuretic peptides and traditional inflammatory markers. Novel inflammatory markers, oxidative stress biomarkers and microRNAs have also been examined as predictors of a successful atrial fibrillation procedure. Notably, the impact of procedural and short-term administration of steroids, as well as the role of colchicine on preventing atrial fibrillation recurrence after ablation is thoroughly presented.Keywords
This publication has 89 references indexed in Scilit:
- Impact of microRNA Expression in Human Atrial Tissue in Patients with Atrial Fibrillation Undergoing Cardiac SurgeryPLOS ONE, 2013
- Acute Pulmonary Vein Isolation Is Achieved by a Combination of Reversible and Irreversible Atrial Injury After Catheter AblationCirculation: Arrhythmia and Electrophysiology, 2012
- Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillationEP Europace, 2012
- Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillationBMC Cardiovascular Disorders, 2011
- Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablationAmerican Heart Journal, 2011
- Statin Therapy for the Prevention of Atrial Fibrillation Trial (SToP AF trial)Journal of Cardiovascular Electrophysiology, 2010
- Relation of Multiple Inflammatory Biomarkers to Incident Atrial FibrillationThe American Journal of Cardiology, 2009
- Protracted CRP Elevation after Atrial Fibrillation AblationPacing and Clinical Electrophysiology, 2008
- Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolationHeart, 2006
- Gene expression profiling of oxidative stress on atrial fibrillation in humansExperimental & Molecular Medicine, 2003